Citation: Jian-Cheng SHI, Xiao-Qian HUANG, Min LUO, Chu-Sheng HUANG. Identification of Novel and Potent Curcuminoids Inhibitors of Tubulin with Anticancer Activities by 3D-QSAR and Molecular Docking[J]. Chinese Journal of Structural Chemistry, ;2020, 39(6): 1157-1166. doi: 10.14102/j.cnki.0254-5861.2011-2545 shu

Identification of Novel and Potent Curcuminoids Inhibitors of Tubulin with Anticancer Activities by 3D-QSAR and Molecular Docking

College of Chemistry and Material, Nanning Normal University, Nanning 530001, China

Corresponding author: Chu-Sheng HUANG, wyc666999@sina.cn
Received Date: 23 July 2019
Accepted Date: 9 January 2020

Fund Project: National Natural Science Foundation of China 21702034National Natural Science Foundation of China 21861007the Research Foundation of Education Bureau of Guangxi Province 200103YB076Natural Science Foundation of Guangxi Province 2017GXNSFBA198089

Figures(9)

The three-dimensional quantitative structure-activity relationships (3D-QSAR) for 37 curcumin derivatives were constructed by CoMFA and CoMSIA methods, respectively. The results showed that the cross validated coefficient (q²) and non-cross-validated coefficient (R²) were 0.711, 0.962 in CoMFA model and 0.774, 0.856 in CoMSIA model, respectively, which suggests that two models are robust and have good exterior predictive capabilities. Based on these two models and the binding mode with tubulin, nine novel curcuminoids inhibitors which could exhibit much higher anticancer potency and efficiently occupy the colchicine binding site of tubulin, were designed. We expect that the results in this paper have the potential to facilitate the process of design and to develop new potent curcumin derivatives with stronger anticancer activities.
- anticancer activity,
- tubulin,
- curcumin derivatives,
- 3D-QSAR,
- molecular docking,
- molecular design
1. [1]
  Wang, R. B.; Zhang, X. J.; Chen, C. S.; Chen, G. L.; Sarabia, C.; Zhang, Q.; Zheng, S. L.; Wang, G. D.; Chen Q. H. Structure-activity relationship studies of 1, 7-diheteroarylhepta-1, 4, 6-trien-3-ones with two different terminal rings in prostate epithelialcell models. Eur. J. Med. Chem. 2017, 133, 208–226. doi: 10.1016/j.ejmech.2017.03.067
2. [2]
  Teiten, M. H.; Gaascht, F.; Eifes, S.; Dicato, M.; Diederich, M. Chemopreventive potential of curcumin in prostate cancer. Genes Nutr. 2010, 5, 61–74. doi: 10.1007/s12263-009-0152-3
3. [3]
  Chen, Q. H. Curcumin-based anti-prostate cancer agents. Anticancer Agents Med. Chem. 2015, 15, 138–156. doi: 10.2174/1871520615666150116102442
4. [4]
  Li, H. H.; Liu, T.; Xuan, H. X.; Fang, S. B.; Zhao, C. Y. A combination of pharmacophore modeling, virtual screening, and molecular docking studies for a diverse set of colchicine site inhibitors. Med. Chem. Res. 2014, 23, 4713–4723. doi: 10.1007/s00044-014-1028-7
5. [5]
  Prise, V. E.; Honess, D. J.; Stratford, M. R. L.; Wilson, J.; Tozer, G. M. The vascular response of tumor and normal tissues in the rat to the vascular targeting agent, combretastatin A-4-phosphate, at clinically relevant doses. Int. J. Oncol. 2002, 21, 717–726.
6. [6]
  Tozer, G. M.; Kanthou, C.; Parkins, C. S.; Hill, S. A. The biology of the combretastatins as tumour vascular targeting agents. Int. J. Exp. Pathol. 2002, 83, 21–38. doi: 10.1046/j.1365-2613.2002.00211.x
7. [7]
  Lu, Y.; Chen, J.; Xiao, M.; Li, W.; Miller, D. D. An overview of tubulin inhibitors that interact with the colchicine binding site. Pharm. Res. 2012, 29, 2943–2971. doi: 10.1007/s11095-012-0828-z
8. [8]
  Nakagawa-Goto, K.; Oda, A.; Hamel, E.; Ohkoshi, E.; Lee, K. H.; Goto, M. Development of a novel class of tubulin inhibitor from desmosdumotin B with a hydroxylated bicyclic B-ring. J. Med. Chem. 2015, 58, 2378–2389. doi: 10.1021/jm501859j
9. [9]
  Yang, J. H.; Yan, W.; Yu, Y. M.; Wang, Y. X.; Yang, T.; Xue, L. L.; Yuan, X.; Long, C. F.; Liu, Z. W.; Chen, X. X.; Hu, M. S.; Zheng, L.; Qiu, Q.; Pei, H. Y.; Li, D.; Wang, F.; Bai, P.; Wen, J. L.; Ye, H. Y.; Chen, L. J. The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in β-tubulin. J. Biol. Chem. 2018, 293, 9461–9472. doi: 10.1074/jbc.RA117.001658
10. [10]
  Massarotti, A.; Coluccia, A.; Silvestri, R.; Sorba, G.; Brancale, A. The tubulin colchicine domain: a molecular modeling perspective. Chem. Med. Chem. 2012, 7, 33-42. doi: 10.1002/cmdc.201100361
11. [11]
  Li, L.; Jiang, S.; Li, X.; Liu, Y.; Su, J.; Chen, J. Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site. Eur. J. Med. Chem. 2018, 151, 482–494. doi: 10.1016/j.ejmech.2018.04.011
12. [12]
  Liu, G. P.; Jiao, Y.; Huang, C. X.; Chang, P. Identification of novel and potent small molecule inhibitors of tubulin with antitumor activities by virtual screening and biological evaluations. J. Comput. Aided Mol. Des. 2019, 33, 659–664. doi: 10.1007/s10822-019-00206-y
13. [13]
  Joshi, P.; Tanwar, O.; Rambhade, S.; Bhaisare, M.; Jain, D. 2-D QSAR studies of steroidal natural products oleanic acid and their semisynthetic derivatives as potent protein tyrosine phosphatase 1B inhibitors. Med. Chem. Res. 2012, 21, 351–361. doi: 10.1007/s00044-010-9529-5
14. [14]
  III Cramer, R. D.; Patterson, D. E.; Bunce, J. D. Comparative molecular field analysis (CoMFA). 1. effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 1988, 110, 5959–5967. doi: 10.1021/ja00226a005
15. [15]
  Kubinyi, H. Ed. 3D QSAR in Drug Design: Theory, Methods and Applications. ESCOM Science Publishers: Leiden 1993.
16. [16]
  Lu, Y. K.; Wang, J.; Hu, Y.; Lin, Y.; Lin, Z. H. Molecular modeling studies of vascular endothelial growth factor receptor tyrosine kinase inhibitors combining molecular docking and 3D-QSAR methods. Chin. J. Struct. Chem. 2013, 5, 679–694.
17. [17]
  Gerhard, K.; Abraham, U.; Thomas, M. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J. Med. Chem. 1994, 37, 4130–4146. doi: 10.1021/jm00050a010
18. [18]
  Cao, H. Y.; Zhang, H. B.; Zheng, X. F.; Gao, D. B. 3D QSAR studies on a series of potent and high selective inhibitors for three kinases of RTK family. J. Mol. Graphics Model. 2007, 26, 236–245. doi: 10.1016/j.jmgm.2006.12.001
19. [19]
  Leong, S. W.; Chia, S. L.; Abas, F.; Yusoff, K. Asymmetrical meta-methoxylated diarylpentanoids: rational design, synthesis and anti-cancer evaluation in-vitro. Eur. J. Med. Chem. 2018, 157, 716–728. doi: 10.1016/j.ejmech.2018.08.039
20. [20]
  Ravelli, R. B. G.; Gigant, B.; Curmi, P. A.; Jourdain, I.; Lachkar, S.; Sobel, A.; Knossow, M. Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain. Nature 2004, 428, 198–202. doi: 10.1038/nature02393
21. [21]
  Lv, Y. Y.; Yin, C. S.; Liu, H. Y.; Yi, Z. S.; Wang, Y. 3D-QSAR study on atmospheric half-lives of POPs using CoMFA and CoMSIA. J. Environ. Sci. 2008, 20, 1433–1438. doi: 10.1016/S1001-0742(08)62545-0
22. [22]
  SYBYL X-2.0, Tripos Inc., St. Louis, Missouri 2012.
23. [23]
  Clark, M.; Cramer, R. D. I.; van Opdenbosch, N. Validation of the general purpose Tripos 5.2 force field. J. Comput. Chem. 1989, 10, 982–1012. doi: 10.1002/jcc.540100804
24. [24]
  Gasteiger, J.; Marsili, M. Iterative partial equalization of orbital electronegativity: a rapid access to atomic charges. Tetrahedron 1980, 36, 3219–3228. doi: 10.1016/0040-4020(80)80168-2
25. [25]
  Pandey, A.; Mungalpara, J.; Mohan, C. G. Comparative molecular field analysis and comparative molecular similarity indices analysis of hydroxyethylamine derivatives as selective human BACE-1 inhibitor. Mol. Divers. 2010, 14, 39–49. doi: 10.1007/s11030-009-9139-7
26. [26]
  Clark, M.; Cramer, R. D.; Opdenbosch, V. N. Validation of the general purpose Tripos 5.2 force field. J. Comput. Chem. 1989, 10, 982–1012. doi: 10.1002/jcc.540100804
27. [27]
  Cramer, R. D.; Bunce, J. D.; Patterson, D. E. Cross-validation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies. Quant. Struct. -Act. Relat. 1988, 7, 18–25. doi: 10.1002/qsar.19880070105
28. [28]
  Huang, C. S.; Tu, W. T.; Luo, M.; Shi, J. C. Molecular docking and design of novel heterodimers of donepezil and huperzine fragments as acetylcholinesterase inhibitors. Chin. J. Struct. Chem. 2016, 35, 839–848.
29. [29]
  Shi, J. C.; Zhao, D.; Luo, M.; Huang, C. S. A mechanism-based 3D-QSAR and DFT approach for the prediction of H5N1 entry inhibitory potency of 3-O-β-chacotriosyl ursolic acid derivatives. Chin. J. Struct. Chem. 2017, 36, 1987–1999.
30. [30]
  Tropsha, A.; Golbraikh, A. Beware of q²! J. Mol. Graph. Model. 2002, 20, 269–276. doi: 10.1016/S1093-3263(01)00123-1
31. [31]
  Joshi, P.; Tanwar, O.; Rambhade, S.; Bhaisare, M.; Jain, D. 2-D QSAR studies of steroidal natural products oleanic acid and their semisynthetic derivatives as potent protein tyrosine phosphatase 1B inhibitors. Med. Chem. Res. 2012, 21, 351–361. doi: 10.1007/s00044-010-9529-5
32. [32]
  Roy, K. On some aspects of validation of predictive quantitative structure-activity relationship models. Expert. Opin. Drug Discov. 2007, 2, 1567–1577. doi: 10.1517/17460441.2.12.1567
1. [1]
  Yao HUANG , Yingshu WU , Zhichun BAO , Yue HUANG , Shangfeng TANG , Ruixue LIU , Yancheng LIU , Hong LIANG . Copper complexes of anthrahydrazone bearing pyridyl side chain: Synthesis, crystal structure, anticancer activity, and DNA binding. Chinese Journal of Inorganic Chemistry, 2025, 41(1): 213-224. doi: 10.11862/CJIC.20240359
2. [2]
  Jian Song , Shenghui Wang , Qiuge Liu , Xiao Wang , Shuo Yuan , Hongmin Liu , Saiyang Zhang . N-Benzyl arylamide derivatives as novel and potent tubulin polymerization inhibitors against gastric cancers: Design, structure–activity relationships and biological evaluations. Chinese Chemical Letters, 2025, 36(2): 109678-. doi: 10.1016/j.cclet.2024.109678
3. [3]
  Bingchuan Geng , Jiangchun Wei , Dan Hu , Xingpiao Jin , Pingping Fan , Yahui Huang , Xiaoxuan Duan , Yipin Zhao , Yonghui Zhang , Zhengxi Hu . Bioassay- and molecular network-guided discovery of PPAP derivatives from Hypericum monogynum with inhibitory activity against cardiac valve calcification. Chinese Chemical Letters, 2026, 37(9): 112069-. doi: 10.1016/j.cclet.2025.112069
4. [4]
  Jingwen Zheng , Yubo Tan , Dazhuang Xu , Gang Liu , Zhixiang Lu . Fluorescence excitation strategies driven by different energy sources: Mechanism, molecular/materials design, and cross-applications. Chinese Chemical Letters, 2026, 37(6): 111552-. doi: 10.1016/j.cclet.2025.111552
5. [5]
  Shiyang Sun , Ning Yang , Yaqiu Mao , Ting Wei , Pengli Wei , Tingting Yang , Yixin Zhang , Jian Yan , Changkai Jia , Yi Li , Xu Cai , Zhiyuan Zhao , Xuesong Feng , Xiaomei Zhuang , Wenpeng Zhang , Junhai Xiao , Pengyun Li , Zhibing Zheng , Song Li . Rational design of VHL-recruiting KRAS^G12C proteolysis-targeting chimeras based on molecular dynamics simulation. Chinese Chemical Letters, 2026, 37(2): 110992-. doi: 10.1016/j.cclet.2025.110992
6. [6]
  Xiantan Lin , Yicong Lv , Xiaoqi Li , Zengshan Yue , Kai Li , Qingyin Wei , Qianxi Wang , Junhua Luo , Xitao Liu . Rational design of a high-efficiency lead halide organic-inorganic hybrid nonlinear optical switch via molecular engineering. Chinese Chemical Letters, 2026, 37(7): 111083-. doi: 10.1016/j.cclet.2025.111083
7. [7]
  Fang-Yuan Chen , Wen-Chao Geng , Kang Cai , Dong-Sheng Guo . Molecular recognition of cyclophanes in water. Chinese Chemical Letters, 2024, 35(5): 109161-. doi: 10.1016/j.cclet.2023.109161
8. [8]
  Zhaoyong Kang , Shen Li , Yan Li , Jingfeng Song , Yangrui Peng , Yihua Chen . Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: An updated review (from 2022 to 2024). Chinese Chemical Letters, 2025, 36(7): 110447-. doi: 10.1016/j.cclet.2024.110447
9. [9]
  Lin Cai , Lina Su , Zhiruo Zhou , Jianhua Liu , Li Li , Fengyang Yu , Jiaqi Li , Wenjin Wang , Pengfei Wang , Sihui Zhan . Ho-Engineered electronic structure of LaFeO₃ for enhanced photocatalytic molecular oxygen activation and water purification. Chinese Chemical Letters, 2026, 37(7): 112158-. doi: 10.1016/j.cclet.2025.112158
10. [10]
  Bairu Meng , Zongji Zhuo , Han Yu , Sining Tao , Zixuan Chen , Erik De Clercq , Christophe Pannecouque , Dongwei Kang , Peng Zhan , Xinyong Liu . Design, synthesis, and biological evaluation of benzo[4,5]thieno[2,3-d]pyrimidine derivatives as novel HIV-1 NNRTIs. Chinese Chemical Letters, 2024, 35(6): 108827-. doi: 10.1016/j.cclet.2023.108827
11. [11]
  Hui Lei , Yingying Jiang , Jiayu Liu , Weifeng Zhang , Fanbo Meng , Jun Mou , Wenyi Liu , Pengcheng Lei , Rui Xiong , Zan Xu , Hang Zhang , Yanjun Wang , Guo-Bo Li , Lingling Yang , Hua-Li Wang . Structure-activity relationship studies of 3,4-disubstitued indole-2-ketone derivatives identify a potent glutaminyl cyclase inhibitor with antitumor activity against breast cancer. Chinese Chemical Letters, 2026, 37(6): 111511-. doi: 10.1016/j.cclet.2025.111511
12. [12]
  Caihong Mao , Yanfeng He , Xiaohan Wang , Yan Cai , Xiaobo Hu . Synthesis and molecular recognition characteristics of a tetrapodal benzene cage. Chinese Chemical Letters, 2024, 35(8): 109362-. doi: 10.1016/j.cclet.2023.109362
13. [13]
  Cheng-Da Zhao , Huan Yao , Shi-Yao Li , Fangfang Du , Li-Li Wang , Liu-Pan Yang . Amide naphthotubes: Biomimetic macrocycles for selective molecular recognition. Chinese Chemical Letters, 2024, 35(4): 108879-. doi: 10.1016/j.cclet.2023.108879
14. [14]
  Yanwei Duan , Qing Yang . Molecular targets and their application examples for interrupting chitin biosynthesis. Chinese Chemical Letters, 2025, 36(4): 109905-. doi: 10.1016/j.cclet.2024.109905
15. [15]
  Li-Ming Cao , Chun-Ting He . Molecular enhancement of platinum electrocatalysts for hydrogen evolution. Chinese Journal of Structural Chemistry, 2026, 45(3): 100814-100814. doi: 10.1016/j.cjsc.2025.100814
16. [16]
  Lingling Lei , Lang Liu , Yi Zhu , Yanni Wang , Zhiyao Li , Yongmin Zhang , Fengrui Yang , Weidong Pan . Molecular probes for in vivo optical imaging of chemotherapy. Chinese Chemical Letters, 2026, 37(10): 112095-. doi: 10.1016/j.cclet.2025.112095
17. [17]
  Xifeng Lu , Pei Su . Design and application of metal-organic frameworks derivatives as 3-electron ORR electrocatalysts for ^•OH generation in wastewater treatment: A review. Chinese Chemical Letters, 2025, 36(11): 110909-. doi: 10.1016/j.cclet.2025.110909
18. [18]
  Yan Cheng , Hua-Peng Ruan , Yan Peng , Longhe Li , Zhenqiang Xie , Lang Liu , Shiyong Zhang , Hengyun Ye , Zhao-Bo Hu . Magnetic, dielectric and luminescence synergetic switchable effects in molecular material [Et₃NCH₂Cl]₂[MnBr₄]. Chinese Chemical Letters, 2024, 35(4): 108554-. doi: 10.1016/j.cclet.2023.108554
19. [19]
  Wenyi Mei , Lijuan Xie , Xiaodong Zhang , Cunjian Shi , Fengzhi Wang , Qiqi Fu , Zhenjiang Zhao , Honglin Li , Yufang Xu , Zhuo Chen . Design, synthesis and biological evaluation of fluorescent derivatives of ursolic acid in living cells. Chinese Chemical Letters, 2024, 35(5): 108825-. doi: 10.1016/j.cclet.2023.108825
20. [20]
  Zhimin Sun , Xin-Hui Guo , Yue Zhao , Qing-Yu Meng , Li-Juan Xing , He-Lue Sun . Dynamically switchable porphyrin-based molecular tweezer for on−off fullerene recognition. Chinese Chemical Letters, 2024, 35(6): 109162-. doi: 10.1016/j.cclet.2023.109162

Get Citation

PDF

XML

Metrics

PDF Downloads(2)
Abstract views(1786)
HTML views(74)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142